返回
D
Didier Blaise
institut paoli calmettes
86H指数
1.6K论文数
3.4W被引数
收录论文 273
发表时间
Pre-Transplant MRD Negativity and Age Under 40 Predict Superior Long-Term Survival in Relapsed/Refractory B-ALL After CAR-T Therapy Bridging to Haploidentical HSCT: A Multicenter Retrospective Study With 6-Year Follow-Up移植前微小残留病阴性及年龄小于40岁预测CAR-T治疗后复发/难治性B-ALL行半相合造血干细胞移植桥接治疗患者的长期生存优势:一项随访6年的多中心回顾性研究
Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study供体和受者EBV血清状态对异基因造血细胞移植后环磷酰胺治疗的急性白血病患者移植结局的影响:EBMT感染性疾病工作组回顾性研究
Peripheral blood stem cells versus bone marrow graft for non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT外周血干细胞与骨髓移植物在含移植后环磷酰胺的非T细胞去除半相合移植治疗二次急性髓系白血病首次完全缓解患者中的比较:一项来自ALWP/EBMT的研究
Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party抗胸腺细胞球蛋白(ATG)或阿仑单抗为基础的移植物抗宿主病预防方案在低强度预处理异基因造血细胞移植(HCT)中的应用:针对40岁及以上首次完全缓解的急性淋巴细胞白血病患者的一项EBMT急性白血病工作组研究
Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation使用移植后环磷酰胺选择无关供者进行异基因移植治疗急性淋巴细胞白血病:欧洲血液与骨髓移植学会急性白血病工作组的分析
Haematologica
IF7.9
TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated versus haploidentical donor transplants in amulti-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationTET2突变不影响接受造血干细胞移植且处于首次缓解期的成人急性髓系白血病患者的预后:欧洲血液与骨髓移植学会全球委员会和急性白血病工作组的多中心回顾性分析显示,配型相合的同胞或无关供者移植与单倍型相合供者移植后的结果相似。
HAEMATOLOGICA
IF7.9

